Erenumab (Anti-CALCRL / CGRPR)
Erenumab (Anti-CALCRL / CGRPR) (A2576-GRP)
Products
Description
Erenumab (Anti-CALCRL/CGRPR) is a fully human monoclonal antibody targeting CGRP receptor (calcitonin gene–related peptide receptor). Erenumab can be used for the prevention of episodic migraine. MW:145.5 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2576 |